Researchers have concluded that although high-intensity statin users experienced a greater risk for influenza-related medical encounters after vaccination, the risk for low- to moderate-intensity statin users did not significantly increase.
Further, Hector S. Izurieta, MD, of the FDA’s Center for Biologics Evaluation and Research, and colleagues said they “found no significant differences in influenza risks between synthetic and nonsynthetic statin users.”
This activity is supported by an educational grant from ViiV Healthcare.
American Heart Association Scientific Sessions
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.